These high attrition rates compared with those of other therapeutic areas can be explained in part by particular characteristics of oncology drugs, 4 including a narrow therapeutic index, complex ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...